-
1
-
-
33644835617
-
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer
-
van den Belt-Dusebout AW, Nuver J, de Wit R, Gietema JA, ten Bokkel Huinink WW, Rodrigus PT, Schimmel EC, Aleman BM & van Leeuwen FE. (2006) Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 24, 467–475.
-
(2006)
J Clin Oncol
, vol.24
, pp. 467-475
-
-
van den Belt-Dusebout, A.W.1
Nuver, J.2
de Wit, R.3
Gietema, J.A.4
ten Bokkel Huinink, W.W.5
Rodrigus, P.T.6
Schimmel, E.C.7
Aleman, B.M.8
van Leeuwen, F.E.9
-
2
-
-
3042636786
-
Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study
-
Eberhard J, Stahl O, Giwercman Y, Cwikiel M, Cavallin-Stahl E, Lundin KB, Flodgren P & Giwercman A. (2004) Impact of therapy and androgen receptor polymorphism on sperm concentration in men treated for testicular germ cell cancer: a longitudinal study. Hum Reprod 19, 1418–1425.
-
(2004)
Hum Reprod
, vol.19
, pp. 1418-1425
-
-
Eberhard, J.1
Stahl, O.2
Giwercman, Y.3
Cwikiel, M.4
Cavallin-Stahl, E.5
Lundin, K.B.6
Flodgren, P.7
Giwercman, A.8
-
3
-
-
84944250648
-
Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study
-
Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR & Travis LB. (2015) Cardiovascular disease mortality after chemotherapy or surgery for testicular nonseminoma: a population-based study. J Clin Oncol 33, 3105–3115.
-
(2015)
J Clin Oncol
, vol.33
, pp. 3105-3115
-
-
Fung, C.1
Fossa, S.D.2
Milano, M.T.3
Sahasrabudhe, D.M.4
Peterson, D.R.5
Travis, L.B.6
-
4
-
-
0034712488
-
Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer
-
Gietema JA, Meinardi MT, Messerschmidt J, Gelevert T, Alt F, Uges DR & Sleijfer DT. (2000) Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer. Lancet 355, 1075–1076.
-
(2000)
Lancet
, vol.355
, pp. 1075-1076
-
-
Gietema, J.A.1
Meinardi, M.T.2
Messerschmidt, J.3
Gelevert, T.4
Alt, F.5
Uges, D.R.6
Sleijfer, D.T.7
-
5
-
-
84874555886
-
Early development of the metabolic syndrome after chemotherapy for testicular cancer
-
de Haas EC, Altena R, Boezen HM, Zwart N, Smit AJ, Bakker SJ, van Roon AM, Postma A, Wolffenbuttel BH, Hoekstra HJ, van Leeuwen FE, Sleijfer DT & Gietema JA. (2013) Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol 24, 749–755.
-
(2013)
Ann Oncol
, vol.24
, pp. 749-755
-
-
de Haas, E.C.1
Altena, R.2
Boezen, H.M.3
Zwart, N.4
Smit, A.J.5
Bakker, S.J.6
van Roon, A.M.7
Postma, A.8
Wolffenbuttel, B.H.9
Hoekstra, H.J.10
van Leeuwen, F.E.11
Sleijfer, D.T.12
Gietema, J.A.13
-
6
-
-
33847330070
-
Components of the metabolic syndrome in long-term survivors of testicular cancer
-
Haugnes HS, Aass N, Fossa SD, Dahl O, Klepp O, Wist EA, Svartberg J, Wilsgaard T & Bremnes RM. (2007) Components of the metabolic syndrome in long-term survivors of testicular cancer. Ann Oncol 18, 241–248.
-
(2007)
Ann Oncol
, vol.18
, pp. 241-248
-
-
Haugnes, H.S.1
Aass, N.2
Fossa, S.D.3
Dahl, O.4
Klepp, O.5
Wist, E.A.6
Svartberg, J.7
Wilsgaard, T.8
Bremnes, R.M.9
-
7
-
-
52249116769
-
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors
-
Haugnes HS, Aass N, Fossa SD, Dahl O, Klepp O, Wist EA, Wilsgaard T & Bremnes RM. (2008) Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors. J Cancer Surviv 2, 128–137.
-
(2008)
J Cancer Surviv
, vol.2
, pp. 128-137
-
-
Haugnes, H.S.1
Aass, N.2
Fossa, S.D.3
Dahl, O.4
Klepp, O.5
Wist, E.A.6
Wilsgaard, T.7
Bremnes, R.M.8
-
8
-
-
84869231872
-
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up
-
Haugnes HS, Bosl GJ, Boer H, Gietema JA, Brydoy M, Oldenburg J, Dahl AA, Bremnes RM & Fossa SD. (2012) Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 30, 3752–3763.
-
(2012)
J Clin Oncol
, vol.30
, pp. 3752-3763
-
-
Haugnes, H.S.1
Bosl, G.J.2
Boer, H.3
Gietema, J.A.4
Brydoy, M.5
Oldenburg, J.6
Dahl, A.A.7
Bremnes, R.M.8
Fossa, S.D.9
-
9
-
-
67650333178
-
A comprehensive definition for metabolic syndrome
-
Huang PL. (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2, 231–237.
-
(2009)
Dis Model Mech
, vol.2
, pp. 231-237
-
-
Huang, P.L.1
-
10
-
-
0142028780
-
Improving treatment outcomes in testicular cancer: strategies to reduce treatment related morbidity
-
Huddart RA. (2003) Improving treatment outcomes in testicular cancer: strategies to reduce treatment related morbidity. BJU Int 92, 524–526.
-
(2003)
BJU Int
, vol.92
, pp. 524-526
-
-
Huddart, R.A.1
-
11
-
-
84922588831
-
Five-year relative survival rate of testis cancer in the USA, Europe and Japan
-
Katanoda K & Matsuda T. (2014) Five-year relative survival rate of testis cancer in the USA, Europe and Japan. Jpn J Clin Oncol 44, 1248.
-
(2014)
Jpn J Clin Oncol
, vol.44
, pp. 1248
-
-
Katanoda, K.1
Matsuda, T.2
-
12
-
-
84965179599
-
Long-term relative survival after diagnosis of testicular germ cell tumor
-
Kvammen O, Myklebust TA, Solberg A, Moller B, Klepp OH, Fossa SD & Tandstad T. (2016) Long-term relative survival after diagnosis of testicular germ cell tumor. Cancer Epidemiol Biomarkers Prev 25, 773–779.
-
(2016)
Cancer Epidemiol Biomarkers Prev
, vol.25
, pp. 773-779
-
-
Kvammen, O.1
Myklebust, T.A.2
Solberg, A.3
Moller, B.4
Klepp, O.H.5
Fossa, S.D.6
Tandstad, T.7
-
13
-
-
17644431109
-
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer
-
Meinardi MT, Gietema JA, van der Graaf WT, van Veldhuisen DJ, Runne MA, Sluiter WJ, de Vries EG, Willemse PB, Mulder NH, van den Berg MP, Koops HS & Sleijfer DT. (2000) Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol 18, 1725–1732.
-
(2000)
J Clin Oncol
, vol.18
, pp. 1725-1732
-
-
Meinardi, M.T.1
Gietema, J.A.2
van der Graaf, W.T.3
van Veldhuisen, D.J.4
Runne, M.A.5
Sluiter, W.J.6
de Vries, E.G.7
Willemse, P.B.8
Mulder, N.H.9
van den Berg, M.P.10
Koops, H.S.11
Sleijfer, D.T.12
-
14
-
-
4544264671
-
Testosterone replacement therapy: current trends and future directions
-
Nieschlag E, Behre HM, Bouchard P, Corrales JJ, Jones TH, Stalla GK, Webb SM & Wu FC. (2004) Testosterone replacement therapy: current trends and future directions. Hum Reprod Update 10, 409–419.
-
(2004)
Hum Reprod Update
, vol.10
, pp. 409-419
-
-
Nieschlag, E.1
Behre, H.M.2
Bouchard, P.3
Corrales, J.J.4
Jones, T.H.5
Stalla, G.K.6
Webb, S.M.7
Wu, F.C.8
-
15
-
-
20544434406
-
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer
-
Nuver J, Smit AJ, Wolffenbuttel BH, Sluiter WJ, Hoekstra HJ, Sleijfer DT & Gietema JA. (2005) The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 23, 3718–3725.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3718-3725
-
-
Nuver, J.1
Smit, A.J.2
Wolffenbuttel, B.H.3
Sluiter, W.J.4
Hoekstra, H.J.5
Sleijfer, D.T.6
Gietema, J.A.7
-
16
-
-
77951642063
-
Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study
-
Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, Bartfai G, Boonen S, Casanueva FF, Giwercman A, Han TS, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Vanderschueren D, Huhtaniemi IT, Wu FC & Group E (2010) Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 95, 1810–1818.
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 1810-1818
-
-
Tajar, A.1
Forti, G.2
O'Neill, T.W.3
Lee, D.M.4
Silman, A.J.5
Finn, J.D.6
Bartfai, G.7
Boonen, S.8
Casanueva, F.F.9
Giwercman, A.10
Han, T.S.11
Kula, K.12
Labrie, F.13
Lean, M.E.14
Pendleton, N.15
Punab, M.16
Vanderschueren, D.17
Huhtaniemi, I.T.18
Wu, F.C.19
-
17
-
-
84952639049
-
The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease
-
Traish AM & Zitzmann M. (2015) The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease. Rev Endocr Metab Disord 16, 249–268.
-
(2015)
Rev Endocr Metab Disord
, vol.16
, pp. 249-268
-
-
Traish, A.M.1
Zitzmann, M.2
-
18
-
-
84880252767
-
Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
-
Willemse PM, Burggraaf J, Hamdy NA, Weijl NI, Vossen CY, van Wulften L, van Steijn-van Tol AQ, Rosendaal FR & Osanto S. (2013) Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors. Br J Cancer 109, 60–67.
-
(2013)
Br J Cancer
, vol.109
, pp. 60-67
-
-
Willemse, P.M.1
Burggraaf, J.2
Hamdy, N.A.3
Weijl, N.I.4
Vossen, C.Y.5
van Wulften, L.6
van Steijn-van Tol, A.Q.7
Rosendaal, F.R.8
Osanto, S.9
-
19
-
-
84936748227
-
International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990
-
Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A & Bray F. (2015) International testicular cancer incidence trends: generational transitions in 38 countries 1900–1990. Cancer Causes Control 26, 151–158.
-
(2015)
Cancer Causes Control
, vol.26
, pp. 151-158
-
-
Znaor, A.1
Lortet-Tieulent, J.2
Laversanne, M.3
Jemal, A.4
Bray, F.5
|